Sensible Biotechnologies raised $47M in Series A funding to develop its cell-based mRNA manufacturing platform, VECTOR, ...

A new review in Medical Oncology details how liquid biomarkers, advanced imaging, and artificial intelligence are transforming pre-biopsy discrimination of prostate cancer from benign disease.

A spatial multi-omics study in Chinese Medical Journal shows that early gastric cancer arises within an inflammation-associated spatial niche governed by a SOX9-CXCL axis that can be disrupted by dual ...

QIAGEN is also introducing the QIAGEN Discovery Platform, which enables the integration of AI with QIAGEN’s biomedical knowledge base and molecular data to support drug discovery. The platform is ...